Ann: Change in substantial holding, page-5

Just not sure if the market is mis pricing

I don't think the market is mispricing too much at this stage. On the basis of the last result, at a S/P of about $2.50, the P/E is sitting at about 35 times which is pretty high for a business who's profit halved from 2021 to 2022.
They provided a range of solid reasons to explain this result but they, along with most other companies, were not confident about providing much of an idea as to the 2023 result through their outlook.
Australian Government statistics for Diagnostic Imaging for the two months to the end of August 2022 were about equal to the number for the same period in 2021 but that was after a reasonable improvement in the counts out of NSW.
Victoria and Queensland number were down a little on last year's numbers and this is where most of our Centres are.
If they could return the current years (2023) result back to the result achieved in 2021, the P/E would be reduced to about 15 and that would suggest that the price is a bit cheap at the current mark.
So, for me, I want to gather some idea as to how 2023 is looking from management at the AGM on 4th November before I buy any more stock.